A real world study assessing a combination of Bortezomib, Lenalidomide and Dexamethasone in transplant ineligible Newly Diagnosed Multiple Myeloma patients
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Bortezomib (Primary) ; Lenalidomide (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 21 Jul 2020 New trial record
- 21 Jun 2020 Results presented at the 25th Congress of the European Haematology Association